+1 858 550 6106 rawerkamp@cooley.com
Ryan Awerkamp focuses his practice on corporate and securities matters for private and public companies, including private financings, M&A, tender offers, public offerings, corporate governance and SEC reporting and compliance.
Download full bio
Synthorx to Sell to Sanofi for $2.5 Billion
Turning Point Therapeutics - $192 Million IPO
ConvergeOne Agrees to Sell to CVC for $1.8 Billion
Allogene Therapeutics – $372.6 Million IPO
Mergers & Acquisitions
Emerging Companies
Capital Markets
Public Companies
Venture Capital
Time with my wife and four daughters
Tennis and basketball
Travel
University of Virginia School of LawJD, 2017
Brigham Young UniversityBA, Economicsmagna cum laude, 2014
California
Synthorx Agrees to Sell to Sanofi for $2.5 Billion December 9, 2019
ConvergeOne Agrees to Sell to CVC for $1.8 Billion November 12, 2018
+1 858 550 6106 office rawerkamp@cooley.com
4401 Eastgate MallSan Diego, CA 92121-1909